Related Experiment Video
Updated: Jul 15, 2026

04:20
Extraction of Diatom DNA from Water Samples and Tissues
Published on: November 10, 2023
From diatomics to drugs and dividends
1Department of Chemistry, University of Oxford, Oxford OX1 3QH, UK. graham.richards@chem.ox.ac.uk
Journal of Molecular Graphics & Modelling
|May 8, 2007
Summary
The journey from studying simple molecules to complex drug discovery is detailed, highlighting the crucial role of computer advancements. This field offers significant future opportunities for innovation and commercialization.
Area of Science:
- Computational chemistry
- Molecular modeling
- Drug discovery
Background:
- The evolution of computational power over 50 years has been integral to scientific progress.
- Early research in diatomic molecule spectroscopy laid foundational principles.
Observation:
- The study traces the historical progression from basic molecular analysis to sophisticated computational approaches.
- Commercialization aspects of scientific research are also discussed.
Findings:
- Molecular modeling, driven by computational advances, has become a key tool in modern drug discovery.
- The interplay between spectroscopy, computation, and application is a recurring theme.
Implications:
- The future of molecular modeling and drug discovery remains promising, with ample room for further development.
- Interdisciplinary collaboration between computation, chemistry, and pharmacology is essential for future breakthroughs.
Related Concept Videos
Drug-Receptor Bonds
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
[4+2] Cycloaddition of Conjugated Dienes: Diels–Alder Reaction
The Diels–Alder reaction is an example of a thermal pericyclic reaction between a conjugated diene and an alkene or alkyne, commonly referred to as a dienophile. The reaction involves a concerted movement of six π electrons, four from the diene and two from the dienophile, forming an unsaturated six-membered ring. As a result, these reactions are classified as [4+2] cycloadditions.
Applications of Molecular Taxonomy
Molecular taxonomy has revolutionized the understanding and classification of bacteria, providing precise insights into their diversity, evolutionary relationships, and ecological roles. By utilizing molecular techniques such as DNA sequencing and fingerprinting, researchers have made significant strides in various fields related to bacterial studies.Resolving Taxonomic AmbiguitiesMolecular taxonomy has been instrumental in distinguishing closely related bacterial species initially thought to...
Drug Biotransformation: Overview
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
Molecular Orbital Theory II
Molecular Orbital Energy Diagrams
